论文部分内容阅读
It is known that immunotherapy and cancer chemotherapy may cause hepatitis B virus(HBV)reactivation in hepatitis B surface antigen carriers and inactive chronic hepatitis B patients.Guidelines recommend antiviral prophylaxis regardless of HBV DNA levels t